I'd gladly take the stock off your hands if you're serious - missed out altogether. In fact, I reckon you'd have a queue lining up, even if you added a small premium onto it.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025